Table 3.

Results of the log-rank test of the Kaplan-Meier analysis for NCT03439332 cohort: (1) all, (2) moderate vascular (rCBV_HAT < rCBVth), and (3) high vascular (rCBV_HAT > rCBVth). For each subpopulation, the mean OS and number of patients with methylated MGMT and unmethylated MGMT are presented. Additionally, differences between OS (days), hazard ratios, area under the curve (AUC), and log-rank test resulting p value are presented

	No. of patients		Median OS
	Meth. MGMT	Unmeth. MGMT	Meth. MGMT	Unmeth. MGMT	ΔOS	HR [95% CI]	p	AUC
All	43	53	507	373	134	2.10 [1.33–3.33]	0.0016	0.61
Moderate rCBV	19	29	678	411	267	2.73 [1.40–5.32]	0.0031	0.70
High rCBV	24	24	444	338	106	1.72 [0.90–3.27]	0.10	0.56